NewcelX NCEL
NASDAQ NCEL
$3.26 -0.11 (-3.18%)
As of: Aug 21, 2026 · 1:20 PM EDT

NewcelX (NCEL) Receivables - Net (2019 - 2025)

NewcelX (NCEL) posted quarterly Receivables - Net of $56000.0 for Q2 2025, down 88.64% year-over-year from $493000.0 in Q2 2024, and down 56.92% quarter-over-quarter from $130000.0 in Q4 2024.

NewcelX (NCEL) Receivables - Net (2019 - 2025) Analysis & Trends

NewcelX (NCEL) has reported Receivables - Net for 6 consecutive years, with $56000.0 the latest figure, recorded in Q2 2025.

  • In Q2 2025, Receivables - Net fell 88.64% year-over-year to $56000.0; the TTM figure through Jun 2025 stood at $56000.0 (down 88.64% YoY), while the FY2024 annual figure was $130000.0, down 71.18% from the prior year.
  • Receivables - Net retreated to $56000.0 in Q2 2025 per NCEL's latest filing, from $130000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $493000.0 in Q2 2024 and bottomed at $56000.0 in Q2 2025.
  • Historically, Receivables - Net has averaged $303500.0 across 4 years, with a median of $345500.0 in 2022.
  • Annual changes were most pronounced in 2023 — Receivables - Net soared 54.45% — and 2025, when it tumbled 88.64%.
  • NewcelX's Receivables - Net stood at $292000.0 in 2022, then surged by 54.45% to $451000.0 in 2023, then slumped by 71.18% to $130000.0 in 2024, then sank by 56.92% to $56000.0 in 2025.
  • Business Quant data shows NCEL's Receivables - Net at $56000.0 in Q2 2025, $130000.0 in Q4 2024, and $493000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 NewcelX 12.54 Mn 10.34 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 56,000.00
Jun 30, 2025 56,000.00
Dec 31, 2024 130,000.00
Dec 31, 2024 130,000.00
Jun 30, 2024 493,000.00
Jun 30, 2024 493,000.00
Dec 31, 2023 451,000.00
Dec 31, 2023 451,000.00
Jun 30, 2023 399,000.00
Jun 30, 2023 399,000.00
Dec 31, 2022 292,000.00
Dec 31, 2022 292,000.00
Dec 31, 2020 67,954.00
Dec 31, 2020 67,954.00
Dec 31, 2019 54,472.00
Dec 31, 2019 54,472.00